CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis.
Pietroboni AM, Schiano di Cola F, Scarioni M, Fenoglio C, Spanò B, Arighi A, Cioffi SM, Oldoni E, De Riz MA, Basilico P, Calvi A, Fumagalli GG, Triulzi F, Galimberti D, Bozzali M, Scarpini E.
Pietroboni AM, et al. Among authors: schiano di cola f.
Mult Scler. 2017 Jul;23(8):1085-1091. doi: 10.1177/1352458516674566. Epub 2016 Oct 17.
Mult Scler. 2017.
PMID: 27754941